BioCentury
ARTICLE | Clinical News

Orathecin rubitecan regulatory update

January 6, 2003 8:00 AM UTC

SUPG submitted the first portion of its Orathecin rubitecan NDA - chemistry, manufacturing and controls. SUPG, which is seeking approval of the oral chemotherapeutic to treat refractory pancreatic can...